Comèl-Netherton syndrome with bacterial superinfection;Comèl-Netherton-syndrom mit bakterieller superinfektion

Hautarzt

Volumn 54, Issue 12, 2003, Pages 1198-1202

  Beljan, G ^a,c   Traupe, H ^a   Metze, D ^a   Sunderkotter C ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Klin/Poliklin Dermatol/Allergol   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Com l Netherton Syndrome; Staphylococcus aureus; Superantigen; Tacrolimus

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DIFLUCORTOLONE VALERATE; FLUCLOXACILLIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE ACEPONATE; RETINOID; STEROID; SUPERANTIGEN; TACROLIMUS; TOPICAL ANTIINFECTIVE AGENT; VITAMIN D DERIVATIVE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIAL SUPERINFECTION; BACTERIUM ISOLATION; CASE REPORT; CHILD; COMEL NETHERTON SYNDROME; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; ELECTRON MICROSCOPY; GENETICS; GENODERMATOSIS; HAIR; HUMAN; IMMUNOLOGY; MALE; OINTMENT; PATHOLOGY; SCHOOL CHILD; SKIN; SKIN DISEASE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; SYNDROME; TREATMENT OUTCOME; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; HAIR; HUMANS; ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROSCOPY, ELECTRON; OINTMENTS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; SUPERINFECTION; SYNDROME; TACROLIMUS;

EID: 0346816584     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0572-8     Document Type: Article

References (23)

1. Comèl M (1949) Ichthyosis linearis circumflexa. Dermatologica 98:133-136
2. Netherton EW (1958) A unique case of trichorrhexis nodosa: "bamboo hairs". Arch Dermatol 78:483-487
3. Wilkinson RD, Curtis GH, Hawk WA (1964) Netherton's disease - trichorrhexis invaginata (bamboo hair) congenital erythroderma and atopic diathesis: a histopathologic study. Arch Dermatol 89:46-54
4. Traupe H (1989) The Comèl-Netherton syndrome. in: Traupe H (ed) The ichtyoses. A guide to clinical diagnosis, genetic counseling, and therapy. Springer, Berlin Heidelberg New York Tokyo, pp 168-178
5. De Wolf K, Ferster A, Sass U et al. (1996) Netherton's syndrome. A case report. Dermatology 192:400-402
6. Sprecher E, Chavanas S, DiGiovanni J et al. (2001) The Spectrum of pathogenetic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 117:179-187
7. Stoll C, Alembik Y, Tchomakov D et al. (2001) Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns 12:237-243
8. Chavanas S, Bodemer C, Rochat A et al. (2000). Mutations in SPINK5, encoding a serine protease inhibtor, cause Netherton syndrome. Nat Genet 25:141-142
9. Komatsu N, Takata M, Otsuki N et al. (2002) Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118:436-443
10. Becker K, Roth R, Peters G (1998) Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol 36:2548-2553
11. Allen A, Siegfried E, Silverman R et al. (2001) Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137:747-750
12. Fartasch M, Williams ML, Elias PM (1999) Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome. Arch Dermatol 135:823-832
13. Mägert HJ, Standker L, Kreutzmann P et al. (1999) LEKT1, a novel 15-domain type of human serine protease inhibitor. J Biol Chem 274:21499-21502
14. Leung DY (2001) Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol 45:13-16
15. Bunikowski R, Mielke M, Skarabis H et al. (2000) Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 105:814-819
16. Van Gysel D, Koning H, Baert MR et al. (2001) Clinicoimmunological heterogenity in Comel-Netherton syndrome. Dermatology 2002:99-107
17. Smith DL, Smith JG, Wong SW, deShazo RD (1995) Netherton's Syndrome: a syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 95:116-123
18. Hartschuh W, Hausser I, Petzoldt D (1989) Successful retinoid therapy of Netherton syndrome. Hautarzt 40:430-433
19. Haußer I, Anton-Lamprecht I (1996) Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr Dermatol 13:183-199
20. Braun RP, Ramelet AA (1997) Failure of cyclosporine in Netherton's syndrome. Dermatology 195:75
21. Al-Daraji WI, Grant KR, Ryan K et al. (2002). Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 118:779-788
22. Pournaras CC, Lubbe J, Saurat JH (2001) Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J Invest Dermatol 116:480-481
23. Suga Y, Tsuboi R, Hashimoto Y et al. (2000). A case of ichthyosis circumflexa sucesfully treated with topical tacrolimus. J Am Acad Dermatol 42:520-522